AzTrials
AzTrials

Oral Surgical ProceduresNCT05715359

Standardized Osteotomy Guides for Free Flap Reconstruction of Continuous Defects of the Jaws - a Simplified Method

An observational study of Oral Surgical Procedures and Surgery, Oral, run by Lund University Hospital at 1 site in Sweden.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of the present project is to evaluate the outcome from reconstruction of the jaws, with a standardized simplified technique, after a continuous defect. The primary objective is to measure recurrence of the tumour is present as a marking for insufficient resection margins. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Reconstruction
Type of treatment
Surgery or procedure
How many people
200 participants
Where
1 siteSweden
Study dates
1 Oct 2023to Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients treated at Skåne University Hospital, Lund, Sweden between 2002-2021 with reconstruction of the jaws using a standardized osteotomy guide.

Who may be able to join

  • Treated at Skåne University Hospital, Lund, Sweden between 2002-2021 with reconstruction of the jaws using a standardized osteotomy guide.

Who cannot join

  • Less than one year follow-up.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sweden1 site
  • Dept Oral and Maxillofacial Surgery

    Lund, 22185

Other trials in Sweden

About this study

The aim of the present project is to evaluate the outcome from reconstruction of the jaws, with a standardized simplified technique, after a continuous defect.

The primary objective is to measure recurrence of the tumour is present as a marking for insufficient resection margins. Secondary objectives are measures of survival of transplanted tissues, registered complications at follow-up and measures of healing between segments of transplanted bone (bone bridging).

Read the detailed description

Subjects The participants in this retrospective survey were consecutive head- and neck malignancy patients referred 2002-2021 to Skåne University Hospital, Lund, Sweden with an osseous proximity or malignancy. The treatment consisted of combined surgical resection and radiotherapy. Patients will be identified through the use of ICD-coding. All patients included underwent a primary functional and aesthetical reconstruction of continuous defects of the jaws with free vascularized tissue transfer adopted to the area of resection with the aid of a standardized osteotomy guide. The subjects eligible for inclusion in this project should present at least 1-year postoperative follow-up.

Patients eligible for inclusion will be notified in newspaper announcement. One announcement in a national newspaper and one announcement in the member newspaper of the Association for oral and neck cancer patients. Patients that are not agreeing to take part in this project are expected to declare this to the primary investigator. A drop-out analysis will be performed on 30 of the not included subjects according to age and gender.

Surgical Method Reconstruction of resected osseous anatomy was performed on the same occasion as tumour resection. Increased resection margins were decided after marginal intraoperative frozen autopsies. The reconstruction was performed aiming for maximal function with the best possible aesthetic outcome. All patients were initially planned to finalize the reconstructive phase with a dental rehabilitation of dentition lost during the oncological treatment. When applicable, a full dental rehabilitation was performed at least 12 months after resection.

Surgically, a non-customized template with dimensions taken from The Brånemark Novum® concept was used. Hence, the in-house template and cutting guide design was based upon a mean dimension of the size and form in a fully-grown individual. A sectioning of the transplant into three pieces, one frontal and two lateral, for reconstruction of the mandibular body was used as the base for the design. The angle between the segments was designed into aslant of thirty degrees.

The template and cutting guide were initially designed for mandibular reconstruction with an osseo-musculo-cuttaneous vascularized fibula graft. With time, the design was also suitable and used for reconstruction of maxillary and midface reconstruction and in cases with other flaps, like the tip and lateral rim of scapula.

Gradually, the cutting guide for the mandibular body angle was also usable when reconstructing the angle between the body and ramus of the mandible. Further, the angle of the guide was also found to be usable for a reconstruction of the maxillary base at the level suitable to a prosthetic reconstruction of the alveolar process and maxillary dentition to fit a mandibular dentition.

From a biomechanical aspect, the transplant was fixated to the anatomical region with a load sharing principle, meaning osteosynthesis not overbridging the segments but only connecting them. Thus, the transplanted bone was partly loaded to catalyse the osteogenesis. For the same reason, the remaining osseous tissues were, in accordance to a previous study, handled predominately without stripping of the periosteum.

All subjects were treated with postoperative RT, having implant supported dental rehabilitation to be performed in radiated tissues. When applicable, dental rehabilitation begun no earlier than 1 year after tumour resection and after radiographic verification of bone bridging between transplanted bone segments. To improve the healing capacity, hyperbaric oxygene therapy (HBO) was performed at a daily basis four weeks before and two weeks after implant insertion. Ten days per oral antibiotic was given with start two days prior to implant insertion. Implants were loaded six months after insertion.

Variables and data collection methods Registrations from patient journals and radiographs will include the following variables

  1. Survival (patient).
  2. Recurrent tumour.
  3. Complications (including tissue survival).
  4. Function.
  5. Healing of bone segment (bone bridging).
  6. Age.
  7. Gender.
  8. Time since tumour resection.
  9. Level of rehabilitation (e.g. dental).
  10. Jaw movements (range).
  11. Pain.
  12. Any problems with per oral nutrition.

The recordings will be collected in an Excel document and the patients will be coded. Identification possibility is limited to the identification of eligible subjects. After that the subjects will be coded and not possible to identify except with the coding list. The coding list will be kept by the primary investigator in a secure, IT-protected server within the Region Skåne. Data analysis and handling will be performed by the investigators on a material not possible to identify individuals in. The results will be presented in a group level without possibility to identify individuals.

Statistical analysis The sample constitutes of a total inclusion from a cohort limited in time, department and treatment method. The project is designed as an observational trial without a group for comparison. Thus, a power-analysis has not been possible to perform, neither is it valued necessary for this project.

Simple statistical analysis including mean, standard deviation and range will be used.

The limit for statistical significance will be set to p<0.05. A two-sided p-value will be used.

Being tested
Reconstruction
Keywords
Maxillofacial, Reconstruction, Osteotomy, Maxilla, Mandible

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ReconstructionProcedure or surgery

    Standardized template for reconstruction of continious defects of the jaws.

Study groups in NCT05715359
Study groupRoleWhat they receive
Reconstruction of jaws.Patients treated with free tissue transfer reconstruction of the jaws.
Receives: Procedure: Reconstruction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reccurence of tumour.

    Reccurent tumour meaning not radical resection margins

    Measured: At least one year follow-up after resection.

Secondary outcomes (2)
  1. Tissue transfer survival

    Survival of tissue transfer meaning vital structures remaining in reconstructed region.

    Measured: At least one year follow-up after resection.

  2. Oral function

    Oral function meaning ability to breathe, chew, swallow and speek.

    Measured: At least one year follow-up after resection.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2023
  2. Study start1 Oct 2023
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05715359
Sponsor's protocol ID
Standardized osteotomy guide
Status last verified
Apr 2024
First submitted
27 Jan 2023
Last updated
11 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Oral Surgical Procedures and Surgery, Oral, run by Lund University Hospital at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 11 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reccurence of tumour. (time frame: At least one year follow-up after resection.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in